Logone Bio-Convergence Research Foundation

Logone Bio-Convergence Research Foundation is a South Korea-based nonprofit biomedical research foundation focused on translational bio-convergence research, companion diagnostics, and contract research services. Publicly visible activity suggests the organization operates laboratory and CRO capabilities rather than a broad commercial therapeutic pipeline, with work spanning biomarker research, molecular diagnostics, oncology-related antibody research, and selected therapeutic invention filings. Its disclosed intellectual property includes a type 1 interferon-neutralizing Fc-fusion protein program, and publications also connect the organization to companion diagnostic development and preclinical pharmacology studies. The foundation appears to collaborate closely with Seoul National University, Abion, and other Korean research institutions. Overall, it looks more like an active health-research foundation and service-oriented translational R&D organization than a conventional venture-backed drug developer.